EXECUTIVE BOARD AND BOARD OF DIRECTORS

Mr. Marcelo Hahn is the founder, board member and CEO of Blau Farmacêutica, which was founded in 1987, after deciding to enter the Brazilian pharmaceutical segment.

Marcelo led the Company's consolidation and expansion and is responsible for defining the overall direction, new business strategy and execution of the company's business plan

Mr. Roberto is the Company's COO and M&A Director, responsible for overseeing Blau's M&A strategy and operation.

Prior to joining Blau, Roberto held board positions in companies of the most varied industries, such as GE Capital, Unibanco AIG Warranty, MHAG Mineração e Serviços, Barrera Pharma Representações Ltda, and even held the position of CEO at São Miguel Holding and Investments.

Roberto has a degree in Mechanical Engineering from Escola Politécnica – USP and an MBA in Marketing from FIA/FEA.

Mr. Douglas Rodrigues is CFO of Blau, where he leads the finance and administrative teams.

Prior to joining as CFO of the Company in May 2018, Douglas served as a member of the management of several health companies, as CFO appointed by Pfizer to the Teuto Laboratory, Pfizer, Wyeth and RaiaDrogasil, as well as companies from other segments (Sika Brasil).

Douglas holds a bachelor's degree in Accounting from FEAO, an extension degree from the University of Pennsylvania, a post-graduate degree from FAAP and an MBA from Insper.

Ms. Eliza Yukie Saito has been Blau's quality director since November 2011, responsible for managing and maintaining quality, in line with national and international standards for Good Manufacturing Practices and Quality Control.

Previously, she held quality management positions at several pharmaceutical companies, such as Bunker Indústria Farmacêutica, Instituto Terapêutico Delta, Brasmédica e Laboratórios Biosintética Ltda. She joined Blau in 2001 as Quality Assurance and Control Manager, and in November 2011 became Quality Director and since October 2016, she has also worked as the Company's Technical Officer before the health surveillance bodies.

Eliza has an undergraduate degree in Biochemical Pharmacy from Faculdade Oswaldo Cruz with specialization in industry, a graduate degree in Biotechnology from Universidade Mogi das Cruzes and Black Belt Certification.

Mr. Roberto Altieri is the Chief Legal Officer, Compliance, Corporate Governance and Data Protection Officer, responsible for overseeing legal, litigation and administrative matters in regulatory, intellectual property, consumer, bidding and administrative, competition, commercial and civil matters in general. He is also responsible for the Compliance, Information Security and Data Protection structure, and the Governance Department.

Before joining the Company as an Officer, he worked as a self-employed lawyer, serving, in addition to the company itself, several companies in the civil construction, agricultural and pharmaceutical sectors such as MPD – Engenharia, Agropec S.A., Laboratório Ativus, Arese Pharma, among others.

Altieri has a degree in Law from the Largo de São Francisco Law School – University of São Paulo, specializing in Public and Private Law

Mr. Rodolfo has a degree in Economic Sciences from the Faculty of Economic Sciences of Buenos Aires – Argentina since 1965. In 1966, he founded Laboratório Terápica Paulista Ltda., later named Ariston Indústrias Químicas e Farmacêuticas Ltda., where he served as Chief Executive Officer until 2007. Mr. Rodolfo has been a member of the Company's Board of Directors since 2011 and is currently the chairman of that body.

Mr. Marcelo Hahn is the founder, board member and CEO of Blau Farmacêutica, which was founded in 1987, after deciding to enter the Brazilian pharmaceutical segment.

Marcelo led the Company's consolidation and expansion and is responsible for defining the overall direction, new business strategy and execution of the company's business plan.

Dr. Antonio Carlos Buzaid graduated from Universidade de São Paulo, where he received the Rockefeller Foundation award for Best Student in Basic Chairs. He completed a Fellowship in Hematology and Oncology at the University of Arizona, where he received the Eleanor B Connel Award for best fellow. Soon after, he was Assistant Professor at Yale University and Medical Director of the Melanoma Center and Co-Director of the University's Lung Cancer Center for 4 years. Thereafter, he was Associate Professor at MD Anderson Cancer Center Hospital and Medical Director of the Multidisciplinary Melanoma and Skin Cancer Center for 5 years. At MDACC, he was awarded the Teacher of the Year award. In 1998, he created, together with Dr Raul Cutait and Frederico Costa, the Oncology Center of Hospital Sírio Libanês. From 1998 to 2010, he was Director of the Oncology Center at Hospital Sírio-Libanês. In 2011, he became General Head of Antonio Ermírio de Moraes Oncology Center of Beneficência Portuguesa in São Paulo and in November 2015, he became a Member of the Management Committee of the Dayan-Daycoval Oncology Center of the Hospital Israelita Albert Einstein.

Mr. José Antônio Miguel Neto graduated in Law in 1985 from Universidade de São Paulo, having worked as a lawyer at the law firm Stroeter, Trench e Veirano Advogados (between 1989 and 1990) and at Johnson and Johnson S/A (between 1985 and 1989). Since 1990, Mr. José Antônio has been a partner at the law firm Miguel Neto Advogados. In addition, Mr. José Antônio served as a judge at the Tax and Fees Court (between 2004 and 2007), in addition to having been a member of the board of directors of Companhia de Concessões Rodoviárias – CCR, Salomão and Zoppi Laboratórios de Diagnósticos S/ A, Banco Fibra SA, Chímica Baruel S/A and FLC – Lâmpadas, among others. Finally, between 2010 and 2012 Mr. José Antônio served as president of Interlegal – World Organization of Lawyers headquartered in London.

Mr. Roberto is the Company's COO and M&A Director, responsible for overseeing Blau's M&A strategy and operation.

Prior to joining Blau, Roberto held board positions in companies of the most varied industries, such as GE Capital, Unibanco AIG Warranty, MHAG Mineração e Serviços, Barrera Pharma Representações Ltda, and even held the position of CEO at São Miguel Holding and Investments.

Roberto has a degree in Mechanical Engineering from Escola Politécnica – USP and an MBA in Marketing from FIA/FEA.

Ms. Andréa has an undergraduate degree in business administration from Faculdade Nuno Lisboa, and graduate degrees and MBAs in the areas of human resources and business administration, with certifications by IBGC, ESPM, ICI USA Zurich Blue Academy and USA ABN Academy. She currently serves as a full member of the IBGC Personnel Committee, of the Board of Directors of Business Professional Women SP, with an executive position at FriendsBee, having already been in charge of the HR board at Scania Brasil, Zurich Seguros, as well as an executive position at Banco Santander, Banco Real and Star One.

Ms. Simone Agra has an undergraduate degree in business administration from Universidade Presbiteriana Mackenzie, and graduate degrees and MBAs in the areas of management, marketing and corporate governance, with certification as an Advisor by the IBGC. Currently, she participates as an effective member of the Audit and Risk Committee and of the Strategy Committee of Hospital Alemão Oswaldo Cruz and Independent Advisor of B2B Synthesis, having already served on the Board of Directors of ABIMED - Brazilian Association of High Technology Industry of Health Products, by the management committee of the Edwards Foundation and board of directors of Edwards Lifesciences, Allergan Pharmaceuticals and BD – Becton Dickinson.